Drugs & Therapy Perspectives

, Volume 19, Issue 2, pp 22–25 | Cite as

Effective Risk Management is the Key to Maximising the Benefits of Self Medication

Practical Issues and Updates


Terfenadine Astemizole Levonorgestrel Adverse Drug Reaction Reporting Multifaceted Approach 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Hughes CM, McElnay JC, Fleming GF. Benefits and risks of self medication. Drug Safety 2001; 24 (14): 1027–37PubMedCrossRefGoogle Scholar
  2. 2.
    Segall A. A community survey of self-medication activities. Med Care 1990; 28: 301–10PubMedCrossRefGoogle Scholar
  3. 3.
    Wearn A, Gill P, Gray M, et al. Pharmacists’ views on deregulating emergency hormonal contraception. Pharm J 2001; 266: 89–92Google Scholar
  4. 4.
    Blenkinsopp A, Bradley C. Patients, society, and the increase in self-medication. BMJ 1996; 312: 629–32PubMedCrossRefGoogle Scholar
  5. 5.
    Soller RW. OTCS 2000: achievements and challenges. Drug Info J 2000; 34: 693–701CrossRefGoogle Scholar
  6. 6.
    Powis MG, Rogers PJ, Wood SM. United Kingdom community pharmacists’ views on recent ‘POM’ to ‘P’ switched medicines. J Soc Admin Pharm 1996; 13: 188–97Google Scholar
  7. 7.
    Erwin J, Britten N, Jones, R. General practitioners’ views on over the counter sales by community pharmacists. BMJ 1996; 312: 617–8PubMedCrossRefGoogle Scholar
  8. 8.
    Sihvo S, Hemminki E, Ahonen R. Physicians’ attitudes towards reclassifying drugs as over-the-counter. Med Care 1999; 37: 518–25PubMedCrossRefGoogle Scholar
  9. 9.
    Tasch RF, Goeree R, Henke CJ, et al. Switching the histamine H2-receptor antagonist famotidine to nonprescription status in Canada. Pharmacoeconomics 1996; 9: 61–75PubMedCrossRefGoogle Scholar
  10. 10.
    Stearns SC, Bernard SL, Fasick SB, et al. The economic implications of self-care: the effect of lifestyle, functional adaptations and medical self-care among a national sample of Medicare beneficiaries. Am J Public Health 2000; 90: 1608–12PubMedCrossRefGoogle Scholar
  11. 11.
    Ferris DG, Dekle C, Kitaker MS. Women’s use of over-the-counter antifungal medications for gynaecological symptoms. J Fam Pract 1996; 42: 595–600PubMedGoogle Scholar
  12. 12.
    Anderson M, Schou JS. Safety implications of over-the-counter availability of H2-antagonists. Drug Saf 1993; 8: 179–85CrossRefGoogle Scholar
  13. 13.
    Holt GA, Hall EL. The self-care movement. In: American Pharmaceutical Association/The National Professional Society of Pharmacists. Handbook of nonprescription drugs. 9th ed. Washington, DC: American Pharmaceutical Society 1990: 1–10Google Scholar
  14. 14.
    Chrischilles EA, Lemke JH, Wallace RB. Prevalence and characteristics of multiple analgesic drug use in an elderly patient study group. J Am Geriatr Soc 1990; 38: 979–84PubMedGoogle Scholar
  15. 15.
    Kogan MD, Pappas G, Yu SM, et al. Over-the-counter medication use among US preschool-age children. JAMA 1994; 272: 1025–30PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited 2003

Personalised recommendations